Package 71335-2598-1

{"route": ["ORAL"], "spl_id": "b117a9ea-a66f-4642-8f50-0f7d8bcae492", "openfda": {"nui": ["N0000175428", "N0000175448"], "unii": ["668Z8C33LU"], "rxcui": ["200258"], "spl_set_id": ["d85abce4-16da-4231-b28a-6afca04ebf68"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-2598-1)", "package_ndc": "71335-2598-1", "marketing_start_date": "20250605"}], "brand_name": "Repaglinide", "product_id": "71335-2598_b117a9ea-a66f-4642-8f50-0f7d8bcae492", "dosage_form": "TABLET", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "71335-2598", "generic_name": "Repaglinide", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Repaglinide", "active_ingredients": [{"name": "REPAGLINIDE", "strength": "2 mg/1"}], "application_number": "ANDA207209", "marketing_category": "ANDA", "marketing_start_date": "20230322", "listing_expiration_date": "20261231"}